nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—Vinblastine—head and neck cancer	0.15	0.393	CbGbCtD
Pranlukast—ABCC2—Docetaxel—head and neck cancer	0.123	0.324	CbGbCtD
Pranlukast—RNASE3—nose—head and neck cancer	0.0763	0.293	CbGeAlD
Pranlukast—IL5—nose—head and neck cancer	0.0693	0.266	CbGeAlD
Pranlukast—CYP2C9—Fluorouracil—head and neck cancer	0.0543	0.143	CbGbCtD
Pranlukast—CYP3A4—Vinblastine—head and neck cancer	0.0293	0.0768	CbGbCtD
Pranlukast—CYP3A4—Docetaxel—head and neck cancer	0.0241	0.0633	CbGbCtD
Pranlukast—IL5—exocrine gland—head and neck cancer	0.0175	0.0669	CbGeAlD
Pranlukast—MUC2—exocrine gland—head and neck cancer	0.0134	0.0515	CbGeAlD
Pranlukast—IL5—connective tissue—head and neck cancer	0.008	0.0307	CbGeAlD
Pranlukast—IL5—epithelium—head and neck cancer	0.00759	0.0291	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—head and neck cancer	0.00644	0.0247	CbGeAlD
Pranlukast—MUC2—connective tissue—head and neck cancer	0.00615	0.0236	CbGeAlD
Pranlukast—IL5—lymphoid tissue—head and neck cancer	0.00585	0.0224	CbGeAlD
Pranlukast—MUC2—epithelium—head and neck cancer	0.00584	0.0224	CbGeAlD
Pranlukast—NFKB1—mouth—head and neck cancer	0.00572	0.0219	CbGeAlD
Pranlukast—NFKB1—parotid gland—head and neck cancer	0.00398	0.0153	CbGeAlD
Pranlukast—NFKB1—saliva-secreting gland—head and neck cancer	0.00382	0.0146	CbGeAlD
Pranlukast—MUC2—head—head and neck cancer	0.00362	0.0139	CbGeAlD
Pranlukast—NFKB1—connective tissue—head and neck cancer	0.00351	0.0134	CbGeAlD
Pranlukast—IL5—lymph node—head and neck cancer	0.0033	0.0127	CbGeAlD
Pranlukast—NFKB1—trachea—head and neck cancer	0.00294	0.0113	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—head and neck cancer	0.00256	0.00983	CbGeAlD
Pranlukast—TNF—lymph node—head and neck cancer	0.00254	0.00973	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—head and neck cancer	0.00252	0.00966	CbGeAlD
Pranlukast—NFKB1—thyroid gland—head and neck cancer	0.00233	0.00893	CbGeAlD
Pranlukast—NFKB1—head—head and neck cancer	0.00207	0.00792	CbGeAlD
Pranlukast—CYSLTR1—head—head and neck cancer	0.00203	0.00778	CbGeAlD
Pranlukast—NFKB1—lymph node—head and neck cancer	0.00145	0.00555	CbGeAlD
Pranlukast—CYSLTR1—lymph node—head and neck cancer	0.00142	0.00545	CbGeAlD
Pranlukast—ABCC2—lymph node—head and neck cancer	0.000568	0.00218	CbGeAlD
Pranlukast—NFKB1—Cellular Senescence—STAT3—head and neck cancer	0.000164	0.000459	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MAPK1—head and neck cancer	0.000164	0.000457	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—EGFR—head and neck cancer	0.000164	0.000457	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	0.000164	0.000457	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000164	0.000457	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—MAPK3—head and neck cancer	0.000163	0.000456	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—head and neck cancer	0.000163	0.000455	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000163	0.000454	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—AKT1—head and neck cancer	0.000162	0.000453	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—MAPK1—head and neck cancer	0.000162	0.000453	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—EGFR—head and neck cancer	0.000162	0.000452	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—HRAS—head and neck cancer	0.000161	0.000448	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—head and neck cancer	0.00016	0.000446	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000157	0.000439	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—MAPK3—head and neck cancer	0.000157	0.000438	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—MAPK1—head and neck cancer	0.000155	0.000434	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—EGFR—head and neck cancer	0.000155	0.000434	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000154	0.000429	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—head and neck cancer	0.000152	0.000426	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—head and neck cancer	0.000152	0.000426	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—MAPK3—head and neck cancer	0.000151	0.000422	CbGpPWpGaD
Pranlukast—IL5—Immune System—CASP8—head and neck cancer	0.00015	0.000418	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—MAPK1—head and neck cancer	0.000149	0.000417	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000148	0.000414	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDH1—head and neck cancer	0.000148	0.000413	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—HRAS—head and neck cancer	0.000147	0.000411	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000146	0.000408	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000146	0.000408	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000146	0.000408	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000146	0.000406	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—head and neck cancer	0.000144	0.000402	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—MAPK1—head and neck cancer	0.000144	0.000401	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—PIK3CA—head and neck cancer	0.000143	0.0004	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000142	0.000397	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—AKT1—head and neck cancer	0.000142	0.000396	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—head and neck cancer	0.000141	0.000395	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2—head and neck cancer	0.000141	0.000393	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—head and neck cancer	0.000139	0.000387	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—head and neck cancer	0.000138	0.000384	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000137	0.000383	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2—head and neck cancer	0.000136	0.000381	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—head and neck cancer	0.000136	0.00038	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KISS1—head and neck cancer	0.000136	0.000378	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—PIK3CA—head and neck cancer	0.000135	0.000377	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.000134	0.000373	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—HRAS—head and neck cancer	0.000133	0.00037	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—head and neck cancer	0.000131	0.000365	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	0.00013	0.000364	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PTEN—head and neck cancer	0.00013	0.000364	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—AKT1—head and neck cancer	0.00013	0.000363	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NOTCH1—head and neck cancer	0.00013	0.000363	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MAPK3—head and neck cancer	0.00013	0.000362	CbGpPWpGaD
Pranlukast—IL5—Immune System—BCL2—head and neck cancer	0.000129	0.000359	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BCL2L1—head and neck cancer	0.000128	0.000357	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000127	0.000354	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—head and neck cancer	0.000125	0.00035	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—head and neck cancer	0.000125	0.00035	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000125	0.000349	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—PIK3CA—head and neck cancer	0.000125	0.000349	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	0.000125	0.000348	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	0.000125	0.000348	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—STAT3—head and neck cancer	0.000124	0.000347	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000124	0.000347	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2—head and neck cancer	0.000124	0.000346	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000124	0.000346	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MAPK1—head and neck cancer	0.000123	0.000345	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—head and neck cancer	0.000123	0.000345	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000123	0.000343	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000122	0.000342	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MAPK3—head and neck cancer	0.000119	0.000331	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—STAT3—head and neck cancer	0.000118	0.000331	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000118	0.000329	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000117	0.000327	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—AKT1—head and neck cancer	0.000117	0.000327	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—STAT3—head and neck cancer	0.000116	0.000325	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000116	0.000324	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—HRAS—head and neck cancer	0.000116	0.000323	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	0.000115	0.000322	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—AKT1—head and neck cancer	0.000115	0.000321	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—MAPK3—head and neck cancer	0.000113	0.000316	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—head and neck cancer	0.000113	0.000316	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MAPK1—head and neck cancer	0.000113	0.000315	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GRP—head and neck cancer	0.000112	0.000312	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000111	0.000311	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000111	0.000311	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MAPK3—head and neck cancer	0.000111	0.000311	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—head and neck cancer	0.000111	0.000309	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	0.00011	0.000308	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STAT6—head and neck cancer	0.000108	0.000302	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	0.000108	0.000301	CbGpPWpGaD
Pranlukast—IL5—Immune System—PTEN—head and neck cancer	0.000106	0.000297	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOTCH1—head and neck cancer	0.000106	0.000297	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MAPK1—head and neck cancer	0.000106	0.000296	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—head and neck cancer	0.000106	0.000296	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CASP8—head and neck cancer	0.000105	0.000292	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000104	0.00029	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—head and neck cancer	0.000104	0.000289	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—UROD—head and neck cancer	0.000104	0.000289	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—AKT1—head and neck cancer	0.000102	0.000285	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.000102	0.000284	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MAPK3—head and neck cancer	9.96e-05	0.000278	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDH1—head and neck cancer	9.92e-05	0.000277	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NOTCH1—head and neck cancer	9.9e-05	0.000276	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—head and neck cancer	9.79e-05	0.000273	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.67e-05	0.00027	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—YAP1—head and neck cancer	9.59e-05	0.000268	CbGpPWpGaD
Pranlukast—IL5—Immune System—STAT3—head and neck cancer	9.52e-05	0.000266	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—head and neck cancer	9.48e-05	0.000265	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—MAPK1—head and neck cancer	9.48e-05	0.000265	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—head and neck cancer	9.47e-05	0.000265	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	9.36e-05	0.000261	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	9.35e-05	0.000261	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—AKT1—head and neck cancer	9.34e-05	0.000261	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PIK3CA—head and neck cancer	9.19e-05	0.000257	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK3—head and neck cancer	9.1e-05	0.000254	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—PIK3CA—head and neck cancer	9.05e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BCL2—head and neck cancer	8.97e-05	0.00025	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—head and neck cancer	8.89e-05	0.000248	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—AKT1—head and neck cancer	8.75e-05	0.000244	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK1—head and neck cancer	8.66e-05	0.000242	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—head and neck cancer	8.66e-05	0.000242	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—HRAS—head and neck cancer	8.65e-05	0.000241	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—HRAS—head and neck cancer	8.5e-05	0.000237	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PIK3CA—head and neck cancer	8.22e-05	0.00023	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	8.19e-05	0.000229	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	8.08e-05	0.000226	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.03e-05	0.000224	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.9e-05	0.000221	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	7.76e-05	0.000217	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	7.66e-05	0.000214	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOTCH1—head and neck cancer	7.63e-05	0.000213	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HRAS—head and neck cancer	7.61e-05	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—head and neck cancer	7.6e-05	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—STAT3—head and neck cancer	7.52e-05	0.00021	CbGpPWpGaD
Pranlukast—IL5—Immune System—PIK3CA—head and neck cancer	7.51e-05	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—AKT1—head and neck cancer	7.51e-05	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2L1—head and neck cancer	7.45e-05	0.000208	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PTEN—head and neck cancer	7.43e-05	0.000207	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AKT1—head and neck cancer	7.4e-05	0.000207	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—head and neck cancer	7.32e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MAPK3—head and neck cancer	7.19e-05	0.000201	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MAPK3—head and neck cancer	7.15e-05	0.0002	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PTEN—head and neck cancer	7.13e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—head and neck cancer	7.13e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Immune System—HRAS—head and neck cancer	6.95e-05	0.000194	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTEN—head and neck cancer	6.89e-05	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MAPK1—head and neck cancer	6.84e-05	0.000191	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—head and neck cancer	6.84e-05	0.000191	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—UROD—head and neck cancer	6.83e-05	0.000191	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—MAPK1—head and neck cancer	6.8e-05	0.00019	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—head and neck cancer	6.8e-05	0.00019	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AKT1—head and neck cancer	6.72e-05	0.000188	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—head and neck cancer	6.5e-05	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK3—head and neck cancer	6.35e-05	0.000177	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—head and neck cancer	6.22e-05	0.000174	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—STAT3—head and neck cancer	6.16e-05	0.000172	CbGpPWpGaD
Pranlukast—IL5—Immune System—AKT1—head and neck cancer	6.14e-05	0.000171	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CASP8—head and neck cancer	6.09e-05	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK1—head and neck cancer	6.04e-05	0.000169	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—head and neck cancer	6.04e-05	0.000169	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDH1—head and neck cancer	6.01e-05	0.000168	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PIK3CA—head and neck cancer	5.9e-05	0.000165	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK3—head and neck cancer	5.88e-05	0.000164	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—head and neck cancer	5.8e-05	0.000162	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—head and neck cancer	5.79e-05	0.000162	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—STAT3—head and neck cancer	5.73e-05	0.00016	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK1—head and neck cancer	5.6e-05	0.000156	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—head and neck cancer	5.6e-05	0.000156	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HRAS—head and neck cancer	5.49e-05	0.000153	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MAPK3—head and neck cancer	5.48e-05	0.000153	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HRAS—head and neck cancer	5.46e-05	0.000152	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—head and neck cancer	5.31e-05	0.000148	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—head and neck cancer	5.25e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PIK3CA—head and neck cancer	5.24e-05	0.000146	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2—head and neck cancer	5.22e-05	0.000146	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MAPK1—head and neck cancer	5.21e-05	0.000145	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—head and neck cancer	5.21e-05	0.000145	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—head and neck cancer	5.12e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PIK3CA—head and neck cancer	5.03e-05	0.000141	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTEN—head and neck cancer	4.94e-05	0.000138	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PIK3CA—head and neck cancer	4.86e-05	0.000136	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HRAS—head and neck cancer	4.85e-05	0.000135	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—head and neck cancer	4.85e-05	0.000135	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—head and neck cancer	4.82e-05	0.000135	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—head and neck cancer	4.7e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HRAS—head and neck cancer	4.66e-05	0.00013	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—head and neck cancer	4.6e-05	0.000128	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.57e-05	0.000128	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.52e-05	0.000126	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HRAS—head and neck cancer	4.49e-05	0.000125	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—head and neck cancer	4.46e-05	0.000125	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—STAT3—head and neck cancer	4.42e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTEN—head and neck cancer	4.33e-05	0.000121	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH1—head and neck cancer	4.32e-05	0.000121	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NAT2—head and neck cancer	4.3e-05	0.00012	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—head and neck cancer	4.28e-05	0.00012	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK3—head and neck cancer	4.22e-05	0.000118	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HRAS—head and neck cancer	4.18e-05	0.000117	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—head and neck cancer	4.11e-05	0.000115	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK1—head and neck cancer	4.02e-05	0.000112	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—head and neck cancer	4.02e-05	0.000112	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—head and neck cancer	3.97e-05	0.000111	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—STAT3—head and neck cancer	3.87e-05	0.000108	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DPYD—head and neck cancer	3.77e-05	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK3—head and neck cancer	3.7e-05	0.000103	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—head and neck cancer	3.69e-05	0.000103	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—YAP1—head and neck cancer	3.58e-05	9.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK1—head and neck cancer	3.52e-05	9.82e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—head and neck cancer	3.52e-05	9.82e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3CA—head and neck cancer	3.49e-05	9.73e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—head and neck cancer	3.37e-05	9.42e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HRAS—head and neck cancer	3.23e-05	9.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PIK3CA—head and neck cancer	3.05e-05	8.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—head and neck cancer	2.97e-05	8.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—head and neck cancer	2.9e-05	8.09e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—head and neck cancer	2.85e-05	7.95e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NAT2—head and neck cancer	2.84e-05	7.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HRAS—head and neck cancer	2.82e-05	7.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTEN—head and neck cancer	2.8e-05	7.81e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.69e-05	7.51e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—head and neck cancer	2.53e-05	7.06e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STAT3—head and neck cancer	2.5e-05	6.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—head and neck cancer	2.49e-05	6.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DPYD—head and neck cancer	2.49e-05	6.94e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK3—head and neck cancer	2.39e-05	6.67e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—YAP1—head and neck cancer	2.36e-05	6.59e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.34e-05	6.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK1—head and neck cancer	2.27e-05	6.35e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—head and neck cancer	2.27e-05	6.35e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TYMS—head and neck cancer	2.15e-05	6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.12e-05	5.93e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX1—head and neck cancer	2.03e-05	5.68e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.01e-05	5.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3CA—head and neck cancer	1.97e-05	5.51e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—head and neck cancer	1.91e-05	5.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HRAS—head and neck cancer	1.83e-05	5.1e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.65e-05	4.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—head and neck cancer	1.61e-05	4.5e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TYMS—head and neck cancer	1.42e-05	3.96e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.4e-05	3.91e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX1—head and neck cancer	1.34e-05	3.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.33e-05	3.71e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.2e-05	3.34e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTEN—head and neck cancer	1.04e-05	2.92e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.9e-06	2.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.37e-06	2.06e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTEN—head and neck cancer	6.89e-06	1.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—head and neck cancer	6.02e-06	1.68e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.86e-06	1.36e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—head and neck cancer	3.97e-06	1.11e-05	CbGpPWpGaD
